淋巴结阳性乳腺癌多模式保乳治疗后的手臂淋巴水肿发生频率与危险因素:一项长期观察
该长期观察纳入385例接受保乳手术、腋窝清扫及局部或局部区域放疗的淋巴结阳性乳腺癌患者,采用LBCQ-D与SDBC-D问卷结合病历回顾分析。中位随访10.1年(4.9-15.9年)时,23.5%(n=43)出现永久性淋巴水肿(II-III期),11.5%(n=23)报告至少一次可逆性淋巴水肿(0-I期)。87.1%的淋巴水肿发生在最初两年内,辅助化疗是显著危险因素(p=0.001;95%CI 7.7-10.2)。
要点
- 中位随访10.1年,23.5%患者出现永久性淋巴水肿(II-III期),11.5%报告可逆性淋巴水肿(0-I期)。
- 87.1%的淋巴水肿发生在最初两年内,尤其是放疗后前两年。
- 辅助化疗是淋巴水肿的显著危险因素(p=0.001;95%CI 7.7-10.2),腋窝清扫术后风险高。
核心结论
- 乳腺癌幸存者面临较高的乳腺癌相关淋巴水肿(BCRL)风险,尤其是接受腋窝清扫者。
- 近90%的BCRL发生在放疗后前两年内。
- 自我报告症状似乎是早期发现BCRL的合适工具。
研究设计与样本
- 长期观察性研究,纳入385例接受多模式治疗(保乳手术、腋窝清扫、局部或局部区域放疗)的淋巴结阳性乳腺癌患者。
- 采用两种经验证的问卷(LBCQ-D和SDBC-D)调查BCRL,并结合病历回顾性数据进行分析。
主要发现
- 中位随访10.1年(范围4.9-15.9年),23.5%(n=43)出现永久性BCRL(II-III期)。
- 11.5%(n=23)报告随访期间至少一次可逆性BCRL(0-I期)。
- 87.1%的淋巴水肿患者在最初两年内发生该情况。
- 辅助化疗是BCRL出现的显著危险因素(p=0.001;95%CI 7.7-10.2)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Arm-lymphedema is a major complication after breast cancer. Recent studies demonstrate the validity of predicting Breast Cancer Related Lymphedema (BCRL) by self-reports. We aimed to investigate the rate of BCRL and its risk factors in the long-term using self-reported symptoms. METHODS: Data was collected from 385 patients who underwent multimodal therapy for nodal positive breast cancer, including breast conserving surgery, axillary dissection, and local or locoregional radiotherapy. Two validated questionnaires were used for the survey of BCRL (i.e. LBCQ-D and SDBC-D). These were analysed collectively with retrospective data of our medical records. RESULTS: 23.5% (n = 43) suffered a permanent BCRL (stage II-III) after a median follow-up time of 10.1 years (4.9-15.9 years); further 11.5% (n = 23) reported at least one episode of reversible BCRL (Stage 0-I) during the follow-up time. 87.1% of the patients with lymphedema developed this condition in the first two years. Adjuvant chemotherapy was a significant risk factor for the appearance of BCRL (p = 0.001; 95%-CI 7.7-10.2). CONCLUSIONS: Breast cancer survivors face a high risk of BCRL, particularly if axillary dissection was carried out. Almost 90% of BCRL occurred during the first two years after radiotherapy. Self-report of symptoms seems to be a suitable instrument of early detection of BCRL.
引用
- Rupp J, Hadamitzky C, Henkenberens C, et al. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer - a long-term observation. Radiat Oncol. 2019. PMID: 30845971. doi:10.1186/s13014-019-1243-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。